Oratoria (Dexamethasone Phosphate)

Dexamethasone phosphate, the active ingredient in Oratoria, is a corticosteroid presented as a sterile powder for injection use. It is employed to treat inflammatory, allergic and autoimmune conditions in adult and pediatric patients.

GNH USA supplies Oratoria as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Oratoria is a corticosteroid that modulates immune and inflammatory pathways in several disease groups. - Acute allergic reactions: reduces swelling, redness and airway obstruction. - Cerebral edema associated with brain tumours or surgery: decreases intracranial pressure. - Severe asthma exacerbations: improves breathing by lowering airway inflammation. - Autoimmune rheumatic diseases: controls systemic inflammation and joint damage. - Certain hematologic malignancies: part of chemotherapy regimens to mitigate cytokine release.

Side effects may occur when dexameth1

Common